Scientific paper - Review paper
Clinical relevance of natural killer cells in breast cancer
Medicina Fluminensis, 58 (2022), 2; 113-120. https://doi.org/10.21860/medflum2022_275128


Cite this document

Gulić, T., Grebić, D., Starčević, A., Avirović, M., Valković Zujić, P., Veljković Vujaklija, D. & Blagojević Zagorac, G. (2022). Clinical relevance of natural killer cells in breast cancer. Medicina Fluminensis, 58. (2), 113-120. doi: 10.21860/medflum2022_275128

Gulić, Tamara, et al. "Clinical relevance of natural killer cells in breast cancer." Medicina Fluminensis, vol. 58, no. 2, 2022, pp. 113-120. https://doi.org/10.21860/medflum2022_275128

Gulić, Tamara, Damir Grebić, Alma Starčević, Manuela Avirović, Petra Valković Zujić, Danijela Veljković Vujaklija and Gordana Blagojević Zagorac. "Clinical relevance of natural killer cells in breast cancer." Medicina Fluminensis 58, no. 2 (2022): 113-120. https://doi.org/10.21860/medflum2022_275128

Gulić, T., et al. (2022) 'Clinical relevance of natural killer cells in breast cancer', Medicina Fluminensis, 58(2), pp. 113-120. doi: 10.21860/medflum2022_275128

Gulić T, Grebić D, Starčević A, Avirović M, Valković Zujić P, Veljković Vujaklija D, and sur.. Clinical relevance of natural killer cells in breast cancer. Medicina Fluminensis [Internet]. 2022 [cited 2024 May 14];58(2):113-120. doi: 10.21860/medflum2022_275128

T. Gulić, et al., "Clinical relevance of natural killer cells in breast cancer", Medicina Fluminensis, vol. 58, no. 2, pp. 113-120, 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:337098. [Accessed: 14 May 2024]

Please login to the repository to save this object to your list.